104 related articles for article (PubMed ID: 12779089)
1. E1AF expression levels are not associated with prognosis in human breast cancer.
Span PN; Manders P; Heuvel JJ; Beex LV; Sweep CG
Breast Cancer Res Treat; 2003 May; 79(1):129-31. PubMed ID: 12779089
[TBL] [Abstract][Full Text] [Related]
2. Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinoma.
Hida K; Shindoh M; Yoshida K; Kudoh A; Furaoka K; Kohgo T; Fujinaga K; Totsuka Y
Oral Oncol; 1997 Nov; 33(6):426-30. PubMed ID: 9509127
[TBL] [Abstract][Full Text] [Related]
3. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
4. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer.
Yigit E; Gönüllü G; Yücel I; Turgut M; Erdem D; Cakar B
Eur J Intern Med; 2008 Dec; 19(8):602-7. PubMed ID: 19046726
[TBL] [Abstract][Full Text] [Related]
5. Hormonal Receptor, Human Epidermal Growth Factor and Its Association with Breast Cancer Tumor Characteristics in Albania.
Pajenga E; Rexha T; Çeliku S; Ugrinska A; Bejtja G
Cent Eur J Public Health; 2016 Sep; 24(3):171-175. PubMed ID: 27760283
[TBL] [Abstract][Full Text] [Related]
6. Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion.
Hiroumi H; Dosaka-Akita H; Yoshida K; Shindoh M; Ohbuchi T; Fujinaga K; Nishimura M
Int J Cancer; 2001 Sep; 93(6):786-91. PubMed ID: 11519038
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and c-erbB-2 (HER2/neu) overexpression status in primary breast cancer patients: an analysis of 158 needle core biopsies.
Vameşu S
Rom J Morphol Embryol; 2007; 48(2):121-9. PubMed ID: 17641798
[TBL] [Abstract][Full Text] [Related]
8. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R
N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446
[TBL] [Abstract][Full Text] [Related]
9. E1AF degradation by a ubiquitin-proteasome pathway.
Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kobayashi M; Totsuka Y; Kohgo T; Shindoh M
Biochem Biophys Res Commun; 2005 Feb; 327(2):575-80. PubMed ID: 15629152
[TBL] [Abstract][Full Text] [Related]
10. Association of E1AF mRNA expression with tumor progression and matrilysin in human rectal cancer.
Liu HY; Zhou B; Wang L; Li Y; Zhou ZG; Sun XF; Xu B; Zeng YJ; Song JM; Luo HZ; Yang L
Oncology; 2007; 73(5-6):384-8. PubMed ID: 18511876
[TBL] [Abstract][Full Text] [Related]
11. E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription.
Jiang J; Wei Y; Liu D; Zhou J; Shen J; Chen X; Zhang S; Kong X; Gu J
Biochem Biophys Res Commun; 2007 Jun; 358(1):53-8. PubMed ID: 17467662
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes.
Hanzawa M; Shindoh M; Higashino F; Yasuda M; Inoue N; Hida K; Ono M; Kohgo T; Nakamura M; Notani K; Fukuda H; Totsuka Y; Yoshida K; Fujinaga K
Carcinogenesis; 2000 Jun; 21(6):1079-85. PubMed ID: 10836994
[TBL] [Abstract][Full Text] [Related]
14. Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer.
Suen D; Chow LW
Biomed Pharmacother; 2006 Jul; 60(6):293-7. PubMed ID: 16828252
[TBL] [Abstract][Full Text] [Related]
15. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
Yamamoto H; Horiuchi S; Adachi Y; Taniguchi H; Nosho K; Min Y; Imai K
Carcinogenesis; 2004 Mar; 25(3):325-32. PubMed ID: 14604892
[TBL] [Abstract][Full Text] [Related]
16. C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.
Lengyel E; Prechtel D; Resau JH; Gauger K; Welk A; Lindemann K; Salanti G; Richter T; Knudsen B; Vande Woude GF; Harbeck N
Int J Cancer; 2005 Feb; 113(4):678-82. PubMed ID: 15455388
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of HER2/neu oncoprotein in serum and tissue samples of women with breast cancer: correlation with clinicopathological parameters.
Farzadnia M; Meibodi NT; Shandiz FH; Mahmoudi M; Bahar MM; Memar B; Amoian S; Maroozi F; Moheghi N
Breast; 2010 Dec; 19(6):489-92. PubMed ID: 20675140
[TBL] [Abstract][Full Text] [Related]
20. E1AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen.
Iwasaki M; Nishikawa A; Akutagawa N; Fujimoto T; Teramoto M; Sakaguchi Y; Kato H; Ito M; Yoshida K; Kudo R
Exp Cell Res; 2004 Oct; 299(2):525-32. PubMed ID: 15350549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
